English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 80 Help

Selected(0)Clear Items/Page:    Sort:
Enzyme/ROS dual-sensitive nanoplatform with on-demand Celastrol release capacity for enhanced ulcerative colitis therapy by ROS scavenging, microbiota rebalancing, inflammation alleviating Journal article
Shi, Jinfeng, Zhou, Jiahui, Liu, Bo, Lin, Kezhou, Xie, Xingliang, Han, Xue, Sheng, Yanmei, Liu, Yihan, He, Congjian, Zhou, Yujin, Zhu, Nan, Yang, Qian, Luo, Ruifeng, Li, Yi. Enzyme/ROS dual-sensitive nanoplatform with on-demand Celastrol release capacity for enhanced ulcerative colitis therapy by ROS scavenging, microbiota rebalancing, inflammation alleviating[J]. Journal of Nanobiotechnology, 2024, 22(1), 437.
Authors:  Shi, Jinfeng;  Zhou, Jiahui;  Liu, Bo;  Lin, Kezhou;  Xie, Xingliang; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:10.6/11.4 | Submit date：2024/08/05
Celastrol  Enzyme/ros-triggered Controlled Release  Ros Scavengers  Ulcerative Colitis  
SSRI antidepressant citalopram reverses the Warburg effect to inhibit hepatocellular carcinoma by directly targeting GLUT1 Journal article
Dong, Fangyuan, He, Kang, Zhang, Shan, Song, Kaiyuan, Jiang, Luju, Hu, Li Peng, Li, Qing, Zhang, Xue Li, Zhang, Naiqi, Li, Bo Tai, Zhu, Li Li, Li, Jun, Feng, Mingxuan, Gao, Yunchen, Chen, Jie, Hu, Xiaona, Wang, Jiaofeng, Jiang, Chongyi, Wang, Cun, Zhu, Helen He, Da, Lin Tai, Ji, Jianguang, Zhang, Zhi Gang, Bao, Zhijun, Jiang, Shu Heng. SSRI antidepressant citalopram reverses the Warburg effect to inhibit hepatocellular carcinoma by directly targeting GLUT1[J]. Cell Reports, 2024, 43(10), 114818.
Authors:  Dong, Fangyuan;  He, Kang;  Zhang, Shan;  Song, Kaiyuan;  Jiang, Luju; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:7.5/8.5 | Submit date：2024/11/05
Aerobic Glycolysis  Drug Discovery  Drug Repurposing  Sert  Slc6a4  
Noncanonical Regulation of HOIL-1 on Cancer Stemness and Sorafenib Resistance Identifies Pixantrone as A Novel Therapeutic Agent for Hepatocellular Carcinoma Journal article
Chen, Peng, Dong, Zheyu, Zhu, Wei, Chen, Junling, Zhou, Yuxin, Ye, Qiuyue, Liao, Xinxin, Tan, Yongfa, Li, Chuanjiang, Wang, Yuhao, Pang, Huajin, Wen, Chunhua, Jiang, Yuchuan, Li, Xiaoqing, Li, Bo, Aimaier, Aihetaimu, Lin, Li, Sun, Jian, Hou, Jiajie, Tang, Libo, Hou, Jinlin, Li, Yongyin. Noncanonical Regulation of HOIL-1 on Cancer Stemness and Sorafenib Resistance Identifies Pixantrone as A Novel Therapeutic Agent for Hepatocellular Carcinoma[J]. Hepatology, 2024.
Authors:  Chen, Peng;  Dong, Zheyu;  Zhu, Wei;  Chen, Junling;  Zhou, Yuxin; et al.
Favorite |   IF:12.9/15.5 | Submit date：2023/08/31
Noncanonical regulation of HOIL-1 on cancer stemness and sorafenib resistance identifies pixantrone as a novel therapeutic agent for HCC Journal article
Chen, Peng, Dong, Zheyu, Zhu, Wei, Chen, Junling, Zhou, Yuxin, Ye, Qiuyue, Liao, Xinxin, Tan, Yongfa, Li, Chuanjiang, Wang, Yuhao, Pang, Huajin, Wen, Chunhua, Jiang, Yuchuan, Li, Xiaoqing, Li, Bo, Aimaier, Aihetaimu, Lin, Li, Sun, Jian, Hou, Jiajie, Tang, Libo, Hou, Jinlin, Li, Yongyin. Noncanonical regulation of HOIL-1 on cancer stemness and sorafenib resistance identifies pixantrone as a novel therapeutic agent for HCC[J]. Hepatology, 2024, 80(2), 330-345.
Authors:  Chen, Peng;  Dong, Zheyu;  Zhu, Wei;  Chen, Junling;  Zhou, Yuxin; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:12.9/15.5 | Submit date：2024/08/05
Hepatocellular-carcinoma  Up-regulation  Inhibition  Activation  Growth  Cells  
Water-Assisted Synthesis of Layer-Controlled CsPbBr3 Nanoplates Spontaneously Encapsulated in PbBr(OH) Journal article
Lian, Zhen Dong, Wang, Bo, Wu, Zhi Sheng, Lin, Hao, Ding, Ting, Wang, Jin Xiao, Zhang, Liang Xing, Xu, Jin Cheng, Xiao, Peng, Xu, Hua, Wang, Shuang Peng, Ng, Kar Wei. Water-Assisted Synthesis of Layer-Controlled CsPbBr3 Nanoplates Spontaneously Encapsulated in PbBr(OH)[J]. Advanced Optical Materials, 2024.
Authors:  Lian, Zhen Dong;  Wang, Bo;  Wu, Zhi Sheng;  Lin, Hao;  Ding, Ting; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:8.0/9.0 | Submit date：2024/05/16
Blue Emission  Cspbbr3 Nanoplates  Growth Dynamics  Pbbr(Oh)  Water-assisted Synthesis  
Consensus statement on research and application of Chinese herbal medicine derived extracellular vesicles-like particles (2023 edition) Review article
2024
Authors:  Zhao, Qing;  Wang, Tong;  Wang, Hongbin;  Cao, Peng;  Jiang, Chengyu; et al.
Favorite | TC[WOS]:6 TC[Scopus]:7  IF:4.7/3.2 | Submit date：2024/02/22
Chinese Herbal Medicine  Consensus  Extracellular Vesicles  Research Application  
Consensus statement on research and application of Chinese herbal medicine derived extracellular vesicles-like particles (2023 edition) Journal article
Zhao, Qing, Wang, Tong, Wang, Hongbin, Cao, Peng, Jiang, Chengyu, Qiao, Hongzhi, Peng, Lihua, Lin, Xingdong, Jiang, Yunyao, Jin, Honglei, Zhang, Huantian, Wang, Shengpeng, Wang, Yang, Wang, Ying, Chen, Xi, Fan, Junbing, Li, Bo, Li, Geng, Liu, Bifeng, Li, Zhiyang, Qi, Suhua, Zhang, Mingzhen, Zheng, Jianjian, Zhou, Jiuyao, Zheng, Lei, Zhao, Kewei. Consensus statement on research and application of Chinese herbal medicine derived extracellular vesicles-like particles (2023 edition)[J]. Chinese Herbal Medicines, 2024, 16(1), 3-12.
Authors:  Zhao, Qing;  Wang, Tong;  Wang, Hongbin;  Cao, Peng;  Jiang, Chengyu; et al.
Favorite | TC[WOS]:6 TC[Scopus]:8  IF:4.7/3.2 | Submit date：2024/09/03
Chinese herbal medicine  consensus  extracellular vesicles  research application  
Compensation peer crash risks and corporate own investments: New evidences from U.S. stock markets Journal article
Lin,Yu En, Jiang,Xiao Tong, Yu,Bo, Lam,Keith S.K.. Compensation peer crash risks and corporate own investments: New evidences from U.S. stock markets[J]. International Review of Financial Analysis, 2023, 89, 102774.
Authors:  Lin,Yu En;  Jiang,Xiao Tong;  Yu,Bo;  Lam,Keith S.K.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:7.5/7.7 | Submit date：2023/08/03
Compensation Peers  Firms' Own Investments  Industry Peers  Peer Crash Risks  Peers' Incentive Effect  
Machine learning model for anti-cancer drug combinations: Analysis, prediction, and validation Journal article
Zhou,Jing Bo, Tang,Dongyang, He,Lin, Lin,Shiqi, Lei,Josh Haipeng, Sun,Heng, Xu,Xiaoling, Deng,Chu Xia. Machine learning model for anti-cancer drug combinations: Analysis, prediction, and validation[J]. Pharmacological Research, 2023, 194, 106830.
Authors:  Zhou,Jing Bo;  Tang,Dongyang;  He,Lin;  Lin,Shiqi;  Lei,Josh Haipeng; et al.
Favorite | TC[WOS]:6 TC[Scopus]:6  IF:9.1/9.0 | Submit date：2023/08/03
Bortezomib (Pubchem Cid: 387447)  Cepharanthine (Pubchem Cid: 10206)  Docetaxel (Taxotere) (Pubchem Cid: 11970251)  Drug Combination Therapy  Flunarizine Dihydrochloride (Pubchem Cid: 5282407)  Lapatinib Ditosylate (Pubchem Cid: 9941095)  Machine Learning  Pazopanib Hydrochloride (Pubchem Cid: 11525740)  Potential Combination Biomarkers  Tamoxifen Citrate (Pubchem Cid: 2733525)  Three-dimensional Tumor Slice Culture  Vatalanib (Pubchem Cid: 151194)  Vincristine (Pubchem Cid: 5978)  Xl-184 (Cabozantinib) (Pubchem Cid: 25102847)  
Highly efficient yellow emission and abnormal thermal quenching in Mn2+-doped Rb4CdCl6 Journal article
Huang,Dayu, Ouyang,Qiuyun, Kong,Youchao, Wang,Bo, Cheng,Ziyong, Al Kheraif,Abdulaziz A., Lian,Hongzhou, Lin,Jun. Highly efficient yellow emission and abnormal thermal quenching in Mn2+-doped Rb4CdCl6[J]. Dalton Transactions, 2023, 52(17), 5715-5723.
Authors:  Huang,Dayu;  Ouyang,Qiuyun;  Kong,Youchao;  Wang,Bo;  Cheng,Ziyong; et al.
Favorite | TC[WOS]:4 TC[Scopus]:5  IF:3.5/3.3 | Submit date：2023/08/03
Perovskite  Nanocrystals